Botanix Pharmaceuticals Limited

ASX:BOT

Botanix Pharmaceuticals Limited

ASX:BOT
TradeAdd trade order Follow Unfollow Set Price Alert
$0.365 (-6.4%)
Last close price
#5
Rank
48
Held by
49
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (2) My Report Forum Investors
Top member reports
Consensus
mmff
Company Report
Last edited 6 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#134
Performance (52m)
-15.5% pa
Followed by
155
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#FDA APPROVAL
stale
mmff
Added 6 months ago
View author's company report

FDA A{{ROVAL GRANTED

Good Luck to all who hold!


Held i

#Study Results #2A 3/2/21
stale
mmff
Added 4 years ago
View author's company report

Phase 2a Study Shows BTX 1801 Eradicates Staphylococcus Aureus

• Top-line data showed that two different BTX 1801 formulations (ointment and gel) were safe, well tolerated and successful at eradicating Staphylococcus aureus.

• Eradication rates as high as 76.2% were obtained at Day 7 for BTX 1801 ointment, with eradication effects extending through to Day 28 of the study to 23.8%, despite no treatment after Day 5

• Botanix continues to assess the clinical utility of synthetic CBD for the treatment of a variety of infections and also develop its proprietary CBD analog assets

View Attachment